[3H]AVP (human, mouse, rat) [7880]
[3H]AVP (human, mouse, rat)
| SMILES |
NC(=O)CC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O |
| InChIKey |
MIFHTMACYGHZKT-LGYYRGKSSA-N |
| Sequence |
CYFQNCPRG |
| HELM |
PEPTIDE1{C.Y.F.Q.N.C.P.R.G.[am]}$$$$ |
Chemical Properties
| Hydrogen bond acceptors |
16 |
| Hydrogen bond donors |
16 |
| Rotatable bonds |
31 |
| Log P |
-5.940 |
| Molecular weight (Da) |
1085.5 |
| Stereochemistry info |
unspecified |
| Radioactive |
3H |
Bioactivities
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
[3H]AVP (human, mouse, rat)
Drug properties
| Molecular type |
Peptide |
| Physiological/Surrogate |
Surrogate |
| Approved drug |
No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Compound is not listed as a drug.